:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/7VWDT6AUJGT6CYRYJTZSQCPH3E.jpg?resize=560%2C380&ssl=1)
The regime of Nicolás Maduro announced this month that it will not approve the use in its territory of the antiquated vaccine of AstraZeneca for the secondary secondary effects which he provoked that his application was suspended in various parts of Europe.
Vice President Delcy Rodríguez informs that “Venezuela does not have permission to evacuate AstraZeneca to be used in the immunization process of our population in relation to the situations, complications, which he presented to those who have been evacuated”.
‘President Nicolás Maduro has decided, taking into account the technical information (…), not to approve and to grant a license to use this vehicle in Venezuelan territory”, Aggregate the function in a televised statement.
The Caribbean country launched in February its Sputnik V evacuation campaign, with health personnel and authorities as a matter of priority, and in March began to apply also to Chinese pharmaceutical company Sinopharm.
Venezuela has between 1.4 and 2.4 million AstraZeneca vacancies by the COVAX World Health Organization (OMS) system.
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/Y7UFSYKKPDQRG3MYHCQJWNPFAU.jpg?resize=560%2C373&ssl=1)
Without embarrassment, it is not possible to read about deeds with the OMS.
Maduro has asked the Panamericana de la Salud (OPS) to manage the evacuation of 300 million dollars from Venezuela blocked in the Bank of England through financial sanctions, led by the United States in order to force the termination of the socialist mandate.
The OPS announcement in February that it was sending to Latin America vacant AstraZeneca and Pfizer.
Various European countries were suspended from vacations with AstraZeneca, between France, Germany, Spain and Italy, for the time being the blood clots and other secondary effects.
The OMS insists on the moon in the use of this vehicle, although it is announced that its experts will meet on March to analyze the situation.
With AFP information
SEGUIR LEYENDO: